Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is Medirom Mrm Stock Sensitive To Interest Rates Price At 1.09 Up 1.39 20260410 Is Euroholdings Ehld Stock Moving Higher Price At 7.50 Up 1.20 20260328 Is Rci Rick Stock A Buy Or Sell Price At 24.15 Up 10.81 20260406 Is Lee Lee Stock Underperforming Price At 8.51 Up 3.40 20260406 Are Short Sellers Targeting Gen Digital Gen Stock Price At 18.71 Up 4.58 20260413 Market Wrap Tech leads modest market gains as consumer sector lags EGY VAALCO Energy posts massive earnings miss as revenue tumbles 25 yearoveryear shares drop 6 Cartesian Therapeutics RNAC Stock Prediction Whats Next Drops Sharply 20260415 Fonterra Cooperative Group Limited FCG Navigating HighYield Opportunities in the New Zealand Dairy Sector Amid Rising Sustainability Concerns Which Stocks Move Against Satellos Bioscience MSLE 019 20260422 Fox Corporation FOX Nvni Group NVNI Stock Why Value Investors Seek It Nudges Down 20260420 What Jyong Biotech MENS management focus reveals about priorities Risk Aversion 20260511 Consolidated Edison ED Core Defensive Dividend Pick for Retirement Portfolios Amid FixedIncome Yield Headwinds GSHD Goosehead Insurance delivers 794 percent Q1 2026 EPS beat as shares fall 515 percent in daily trading Is BioAtla BCAB stock reacting to key levels Q4 2025 Earnings Beat Estimates PEW GrabAGun reports better than expected Q4 2025 EPS but stock edges lower in todays trading Citius Pharma CTXR posts widerthanexpected quarterly loss missing estimates by 45 percent shares slip 185 percent How Gabelli GLU is navigating logistics challenges BlackRock Eyes MultibillionDollar Stake in SpaceX IPO Report Says JPMorganLed Bank Group Tightens Credit Line on KKR Private Credit Fund as Losses Deepen TripAdvisor TRIP Q1 2026 Disappoints EPS 011 Below 007 Views Republic Services RSG Q1 2026 Earnings Surprise EPS 170 Up Significant Coeptis COEP Trading at 1640 Key Decision Point 20260519 Bausch Lomb BLCO Reports Strong Q1 2026 Revenue NA EPS Beats Calamos Conv CHI Steady at 1251 Awaiting Next Catalyst 20260514 Duke Energy DUK Stock Down 162 Support Test at 11519 20260515 Dropbox Defends Fully Remote Model as Corporate ReturntoOffice Trend Gains Momentum Tether Acquires SoftBanks Stake in Twenty One Capital Deepening Bitcoin Commitment Steel Stocks Rally as Government Extends Minimum Import Price on 66 Steel Products Elon Musk Loses HighProfile OpenAI Lawsuit Legal Strategy Likely to Continue Standard Chartered to Slash Corporate Roles by Over 15 in Efficiency Drive Tropic Launches AIPowered Intelligence Hub Integrates Procurement Data into ChatGPT Wholesale Inflation Surges 6 Annually in April Marking Largest Increase Since 2022 UK Exports to US Plunge 25 Following Trumps Liberation Day Tariffs Trade Balance Turns Negative IRS Settlement Halts Tax Audits on President Trump and Family Businesses CCB Q1 2026 Earnings EPS Falls 261 Below Estimates LeonaBio Inc LONA Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Reaction KKR Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Movement MLSS Q1 2026 Earnings NarrowerThanExpected Loss Per Share RDN Q1 2026 Earnings EPS Beat Sends Stock Lower Despite Positive Surprise Gesher Acquisition Corp II Warrants GSHRW Hold Steady at 022 Amid Quiet Trading BEPJ Edges Higher as Perpetual Preferred Note Shows Resilience at 2499 Enerpac Tool Group EPAC Holds Steady Near 3458 as Consolidation Continues Jaguar Health JAGX Surges 687 as Shares Test Critical Resistance at 327 The fundamentals driving KLA Corporation KLAC everyone should understand Breakdown Watch 20260508 CVS Health Corporation CVS PreEarnings Analysis Q1 2026 Outlook Risk Drivers and Investment Implications What Wall Street expects from Dave PLAY this quarter PLAY Dave Busters Q1 Earnings Miss by 384 Shares Under Pressure The merger with Time Warner in 1996 valued at billions validated the contentcentric strategy that Turner pioneered Indaptus Therapeutics INDP Stock Is It a Good Entry Point Indaptus Therapeutics misses EPS views no revenue